paperBrain tumor✓ VerifiedVC0095
Vadla R et al. · Neuro-oncology · 2025-11-01
BRD2 regulates GBM cell-state plasticity and therapy response.
DOIPubMed
paperBrain tumor✓ VerifiedVC0066
Hara T et al. · Cancer cell · 2025-05-27
Hara et al.: immune–cancer interactions drive MES-like transitions in GBM.
DOIPubMed
paperBrain tumor✓ VerifiedVC0059
Neftel C et al. · Cell · 2019-07-18
Neftel et al.: four GBM malignant states (NPC/OPC/AC/MES), plasticity and genetics.
DOIPubMed
preprint✓ VerifiedVC0139
Metzner E, Guruvayurappan K, Southard KM, Ardy RC, Dey KK, Norman TM. · bioRxiv · 2026-10-12
Norman/Dey labs (MSKCC): CRISPRa Multiome Perturb-seq of 119 TFs + dual-guide Perturb-seq of 1,225 TF pairs in RPE-1; chromatin priming predicts emergent states; Mosaic (Transformer) predicts TF-pair interaction residuals (r=0.484) and nominated a validated triple-TF combination.
DOI
datasetBrain tumor✓ VerifiedVC0060
Ruiz-Moreno C et al. · Neuro-oncology · 2025-10-01
GBmap: single-cell & spatial reference atlas of IDH-wt GBM (>1M cells).
DOIPubMed
preprintBrain tumor✓ VerifiedVC0092
Khan SM et al. · bioRxiv · 2025-04-04
Spatial architecture of GBM from core to edge; niche-specific states.
DOI